MET and breast cancer: The search for therapy targets in tumors that still lack those is ongoing and a recent study just analyzed the possibility of using MET inhibitors for basal-like and triple-negative breast cancers, as the role of MET has been described in breast cancer development and these aggressive tumors lack other targets for approach.